According to Novartis, the pre-production and production processes have resumed for some Novartis Animal Health brands. Production and packaging of Clomicalm® 5 mg strength has resumed at the Lincoln plant and shipment began in June 2012. Testing that is required before full scale production is possible has been initiated for Sentinel® Flavor Tabs. However, Novartis cannot yet give exact dates as to when Sentinel will resume shipment.
Novartis is assuring consumers that it has “invested significant resources to achieve the swiftest resolution of this issue” and they’re “working hard to ensure that normal production resumes as promptly as possible.” Novartis’ production suspension was first reported in January 2012, learn more.